vTv Therapeutics Inc
NASDAQ:VTVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
US |
|
UBM Development AG
F:2U2
|
AT |
|
C
|
Coca-Cola Co
XHAN:CCC3
|
US |
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
US |
|
P
|
PixArt Imaging Inc
TPEX:3227
|
TW |
|
Brighthouse Financial Inc
NASDAQ:BHF
|
US |
|
Usio Inc
NASDAQ:USIO
|
US |
|
F
|
Figeac Aero SARL
SWB:1F1
|
FR |
|
Masi Agricola SpA
MIL:MASI
|
IT |
|
B
|
Broadcom Inc
XHAN:1YD
|
US |
|
S
|
South32 Ltd
JSE:S32
|
AU |
|
HonPrecision Inc
TWSE:7769
|
TW |
|
Superior Group of Companies Inc
F:6G6
|
US |
|
B
|
BAWAG Group AG
XETRA:0B2
|
AT |
Wall St Price Targets
VTVT Price Targets Summary
vTv Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VTVT is 55.896 USD with a low forecast of 45.45 USD and a high forecast of 70.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VTVT's stock price target?
Price Target
55.896
USD
According to Wall Street analysts, the average 1-year price target for
VTVT is 55.896 USD with a low forecast of 45.45 USD and a high forecast of 70.35 USD.